Cargando…
HSV-2 Vaccine: Current Status and Insight into Factors for Developing an Efficient Vaccine
Herpes simplex virus type 2 (HSV-2), a globally sexually transmitted virus, and also one of the main causes of genital ulcer diseases, increases susceptibility to HIV-1. Effective vaccines to prevent HSV-2 infection are not yet available, but are currently being developed. To facilitate this process...
Autores principales: | Zhu, Xiao-Peng, Muhammad, Zaka S., Wang, Jian-Guang, Lin, Wu, Guo, Shi-Kun, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939461/ https://www.ncbi.nlm.nih.gov/pubmed/24469503 http://dx.doi.org/10.3390/v6020371 |
Ejemplares similares
-
Review of mathematical models of HSV-2 vaccination: Implications for vaccine development
por: Spicknall, Ian H., et al.
Publicado: (2019) -
Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum
por: Ishfaq, Muhammad, et al.
Publicado: (2020) -
Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs
por: Bernard, Marie-Clotilde, et al.
Publicado: (2015) -
Zika Vaccine Development: Current Status
por: Poland, Gregory A., et al.
Publicado: (2019) -
Current status and progress of the development of prostate cancer vaccines
por: Wang, Jie, et al.
Publicado: (2023)